News

ESU introduces new kidney-transplant masterclass

The number of candidates on the waiting list for a kidney transplant is increasing. With donor figures and characteristics changing over time, further development of kidney transplant preservation techniques is needed. Customisation of immunosuppression to adapt to the characteristics...

New Guidelines-based e-course focuses on men’s health

Get your comprehensive overview on relevant andrology updates via the new e-course, EAU Guidelines on Men’s Health, courtesy of the European School of Urology (ESU). The latest EAU Guidelines on non-neurogenic Lower Urinary Tract Symptoms (LUTS), infertility, sexual dysfunction,...

Call for Applications: EAU RF Unveils New Seeding Grant

The EAU Research Foundation (EAU RF) is announcing a new seeding grant, with the aim of supporting highly innovative and original research by a junior investigator. The call for applications is currently open, with the deadline closing on March...

PCa17: Interactive, compact meeting opens in Vienna

Challenges in diagnosis, staging and patient selection were among the issues taken up in the first plenary session of the EAU Update on Prostate Cancer (PCa17) opened in Vienna today. With more than 300 participants including faculty and exhibitors,...
Click to go to the course

ESU introduces new urolithiasis e-course in collaboration with EULIS

The EAU Education Online course Introduction to Upper Urinary Tract Endoscopy for Stones is the latest installment to a series of highly-informative e-courses designed to equip junior urologists and to refresh the more experienced with the latest in ureteroscopic stone...

BALTIC17: Treatment strategies in urological malignancies

The 4th Baltic Meeting in conjunction with the EAU (BALTIC17) which will be held on May 26 and 27 in Vilnius, Lithuania, will examine current challenges in treatment strategies for urological malignancies, stone disease and functional urology, aside from...

Movember UROwebinar: Debate on screening for PCa

Early screening for prostate cancer has long been a controversial topic for urologists and oncologists alike. On the one hand it can detect cancer while it can still be treated, but on the other hand it also risks overtreatment...